Savaria Corp (SIS.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Savaria Corp (SIS.TO)

29.22

+0.42 (1.46%)

as of Jun 26, 2026, 8:00:01 pm Market Open.

306 watching

Investor Insights

Jun 26, 2026, 12:00 am

This summary was created by AI, based on 6 opinions in the last 12 months.

Savaria Corp (SIS-T) has garnered attention from various experts due to its favorable market positioning and growth potential, particularly in the accessibility industry. The company's strategic shift toward European markets and its focus on U.S.-based production have helped mitigate the impact of previous tariff challenges. Analysts note that Savaria's products are largely FDA-regulated, making them compliant with CUSMA regulations, which is a significant advantage. With an aging population increasingly inclined to age at home, the demand for Savaria's offerings appears robust. Additionally, cost reduction strategies and product innovation are seen as key drivers for future growth, making it a compelling long-term investment with a current yield of 2.69% and a price target of $24.44.

Consensus

Positive

Valuation

Fair Value

Similar

Invacare, IVC

BUY

Stair lifts and mobility aids. Huge demographic tail winds. A very well managed company. A good distribution network in Canada. He really likes the company. Great growth ahead and a great segment to be in.

COMMENT

He doesn’t cover this one formally, but did put it in one of his portfolios because he likes it. Thinks there is lots of opportunity here. Management knows what they are doing. The growth rate is there. Valuation is acceptable. He likes the demographic play they have on the healthcare market. Management owns a big chunk.

TOP PICK

Health care sector. Most of the rest in the sector is too expensive. They make accessibility equipment for the mobility challenged and do the conversion of minivans. It is a unique company. The family owns 50% of the stock.

SELL

Two businesses. One is for in-home lift systems. The second is elevators in your home for cars. The demographics for the medical lifts are obviously quite positive, but the others are negative. He sold because it was getting pricy.

TRADE

Made $0.16 a share last year and $0.13 last nine months. Agrees that demographics are important and this industry is growing. Cdn$ is negative for them. Have a strategy to buy distributors in North America.

BUY

A microcap. Trading at about 15 X EPS forward multiple. Nice growth through the years but are exposed to the US$. Reducing costs and making an acquisition. Margins should go up.

Showing 121 to 126 of 126 entries

Most Recent Experts

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Andrey Omelchak

LionGuard Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Savaria Corp (SIS.TO)